Treatment with Armolipid Plus led to a significant reduction of total cholesterol ( -@ % ) and low-density lipoprotein-cholesterol ( -@ % ) , similar to pravastatin ( -@ % and -@ % , respectively ) , and an increase of high-density lipoprotein-cholesterol ( @ % ) .